This is a session recorded from DPHARM 2022.

As the competition to recruit patients for clinical trials increases and sites are burdened by staffing shortages, technology shifts and more, how can innovative trial designs reduce patient, site and investigator burden?

Designing for patient centricity – reducing the burden for patients, sites and investigators
Addressing organizational implementation challenges
Engaging in collaborative partnerships and innovation to operationalize and deliver innovative trials designs

Speakers:

Victoria L. Chiou, MD, Head of Clinical Excellence and Innovation, AstraZeneca
Sheryl Jacobs, VP, Global Development Operations, Amgen
Camilla Richmond, MD, MA, Medical Director, Translational Medicine, Takeda
Daniel Millar, MBA, Senior Director, Strategic Business Transformation, Janssen Research & Development, LLC

Innovative Trial Designs to Reduce Patient, Site and Investigator Burden

Share

Embed